Navigation Links
Targeting children effective use of limited supplies of flu vaccine and could help control flu spread
Date:6/17/2009

Targeting children may be an effective use of limited supplies of flu vaccine, according to research at the University of Warwick funded by the Wellcome Trust and the EU. The study suggests that, used to support other control measures, this could help control the spread of pandemics such as the current swine flu.

As the World Health Organization declares a pandemic global H1N1 swine flu, countries are looking at measures to control the spread of the disease. These measures include the use of antiviral treatment, social distancing (for example, closing schools and stopping public transport) and quarantining infected individuals.

Pharmaceutical companies have also stepped up production of vaccines effective against this particular strain of the virus. However, if the spread of the disease increases significantly in the autumn, as some scientists predict, it is unlikely that supplies of the new vaccine will be sufficient to vaccinate entire populations.

In research published in the journal Epidemiology and Infection, Dr Thomas House and Professor Matt Keeling from the University of Warwick's Department of Biological Sciences have used computer modelling to predict the spread of pandemic influenza and to look at ways of controlling it effectively, particularly where supplies of vaccine are not sufficient for universal coverage.

The researchers showed that, as might be expected, the disease is likely to spread fastest in densely-populated conurbations, suggesting that these should be priority areas for tackling the spread. However, they showed that vaccinating entire households at random was an inefficient use of resources; instead, vaccinating key individuals offered sufficient protection to others in their household.

Although a simplification of the complex reality of pandemic flu transmission, the researchers believe their model provides a robust argument for vaccinating children.

"Our models suggest that the larger the household which in most cases means the more children living at home the more likely the infection is to spread," says Professor Keeling. "This doesn't mean that everyone in the household needs to be vaccinated, but suggests that vaccination programmes for children might help control a potential pandemic."

The researchers argue that targeting children for vaccination would not only help protect those at greatest risk of exposure to the virus, but would also offer protection to unvaccinated adults. This so-called "herd immunity" effect would mean that significantly less vaccine would be necessary to help control the spread of the virus than if it were offered to everyone.

"Given that children are generally at particular risk from the disease, we believe that vaccination programmes for the young can be justified," says Dr House. "Although not sufficient to prevent a pandemic in themselves, such steps may support other control measures such as social distancing, antiviral drugs or quarantine."

The current study focuses on household transmissions. In the event of a disease outbreak, other modes of transmission are also likely, such as at work or on public transport. However, data for these modes is harder to come by. Professor Keeling and Dr House, together with colleagues at the University of Liverpool, are currently running www.contactsurvey.org, a survey on contact patterns which they hope will help to quantify the relative importance of each context.

"We think it is unlikely that including these other contexts in our model will change the conclusion regarding vaccinating children," says Dr House. "In every city studied, households are seen to play a key role in the transmission of close-contact diseases like influenza."


'/>"/>

Contact: Kelly Parkes-Harrison
k.e.parkes@warwick.ac.uk
44-782-454-0863
University of Warwick
Source:Eurekalert

Related biology news :

1. Targeting nerve growth factor may cure liver cancer
2. Gene-targeting pioneer Mario Capecchi shares 2007 Nobel Prize in Medicine
3. Yale chemist receives NIH Young Investigator Award for antibody targeting
4. Titanium Group Announces Launch of New Identification Solution Targeting High Growth Retail Sector
5. Tumor-targeting viral therapy slows neuroblastoma, malignant peripheral nerve sheath tumors
6. AACR annual meeting showcases developments in understanding and targeting cancers
7. Motor nerve targeting to limb muscles is controlled by ephrin proteins
8. Twin nanoparticle shown effective at targeting, killing breast cancer cells
9. Peregrines PS-targeting antibodies highlighted in AACR Annual Meeting studies
10. Fat still on the childrens menu
11. Many parents at-risk for cancer disclose genetic test results to children
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2016)... WearablesResearch.com , a brand of Troubadour Research & ... Q1 wave of its quarterly wearables survey. A particular ... a program where they would receive discounts for sharing ... "We were surprised to see that so many ... CEO of Troubadour Research, "primarily because there are segments ...
(Date:4/26/2016)... and LONDON , April ... part of EdgeVerve Systems, a product subsidiary of ... today announced a partnership to integrate the Onegini ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... their customers enhanced security to access and transact ...
(Date:4/14/2016)... 2016 BioCatch ™, the ... announced the appointment of Eyal Goldwerger as ... Goldwerger,s leadership appointment comes at a time of ... deployment of its platform at several of the world,s ... discerns unique cognitive and physiological factors, is a winner ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... NEW YORK , June 23, 2016 ... the trading session at 4,833.32, down 0.22%; the Dow Jones ... the S&P 500 closed at 2,085.45, down 0.17%. Stock-Callers.com has ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ... BIND Therapeutics Inc. (NASDAQ: BIND ). Learn more ...
(Date:6/23/2016)... ... June 23, 2016 , ... Velocity Products, ... tools designed, tuned and optimized exclusively for Okuma CNC machining centers at The ... of a collaboration among several companies with expertise in toolholding, cutting tools, machining ...
(Date:6/22/2016)... , June 22, 2016 Cell ... will allow them to produce up to one ... one lot within one week. These high-quality, consistent ... laboriously preparing cells and spend more time doing ... through a proprietary, high-volume manufacturing process that produces ...
Breaking Biology Technology: